bepafant has been researched along with Lung Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allard, JD; Ambruso, DR; Elzi, DJ; Johnson, JL; Silliman, CC; Tuder, RM; Voelkel, NF | 1 |
| Anderson, BO; Banerjee, A; Bensard, DD; Harken, AH; Nelson, DW; Pitman, JM; Poggetti, RS; Shanley, PF; Whitman, GJ | 1 |
2 other study(ies) available for bepafant and Lung Diseases
| Article | Year |
|---|---|
Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model.
Topics: Acute Disease; Adult; Animals; Azepines; Benzimidazoles; Blood Preservation; Blood Pressure; Calcium; Calcium Channel Blockers; Humans; Leukotriene E4; Lipids; Lung Diseases; Lysophosphatidylcholines; Male; Mibefradil; Neutrophil Activation; Neutrophils; Platelet Aggregation Inhibitors; Pulmonary Artery; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Transfusion Reaction; Triazoles | 1998 |
Primed neutrophils injure rat lung through a platelet-activating factor-dependent mechanism.
Topics: Animals; Azepines; Lipopolysaccharides; Lung; Lung Diseases; Male; Neutrophils; Nitroblue Tetrazolium; Oligopeptides; Peroxidase; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serum Albumin; Staining and Labeling; Triazoles | 1991 |